These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 848977)

  • 1. Phenytoin-induced pseudolymphoma syndrome: an immunologic study.
    Charlesworth EN
    Arch Dermatol; 1977 Apr; 113(4):477-80. PubMed ID: 848977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome.
    D'Incan M; Souteyrand P; Bignon YJ; Fonck Y; Roger H
    Arch Dermatol; 1992 Oct; 128(10):1371-4. PubMed ID: 1417026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythroderma, hypogammaglobulinemia, and T-cell lymphocytosis. Occurrence following therapy with phenytoin.
    Lillie MA; Yang LC; Honig PJ; August CS
    Arch Dermatol; 1983 May; 119(5):415-8. PubMed ID: 6221698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro.
    Sorrell TC; Forbes IJ
    Clin Exp Immunol; 1975 May; 20(2):273-85. PubMed ID: 1212810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin-related immunodeficiency associated with Loeffler's syndrome.
    Lazoglu AH; Boglioli LR; Dorsett B; Macris NT
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):479-82. PubMed ID: 7788513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report of antiepileptic drug hypersensitivity reaction: pseudolymphoma syndrome.
    Black DM; Fivenson DP
    Fam Pract Res J; 1989; 8(2):107-11. PubMed ID: 2662706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphadenopathy in phenytoin treatment (author's transl)].
    Seyfeddinipur N
    Dtsch Med Wochenschr; 1976 Oct; 101(40):1454-6. PubMed ID: 823005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin-induced pseudolymphoma with mycosis fungoides manifestations.
    Cooke LE; Hardin TC; Hendrickson DJ
    Clin Pharm; 1988 Feb; 7(2):153-7. PubMed ID: 3349752
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphoma or pseudolymphoma?
    Kruspe R; Broussard A; Santanilla J; Gupta S; Espinoza C; Lopez FA; Kantrow S
    J La State Med Soc; 2002; 154(4):178-81; quiz 181-2. PubMed ID: 12236400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin in cutaneous medicine: its uses, mechanisms and side effects.
    Scheinfeld N
    Dermatol Online J; 2003 Aug; 9(3):6. PubMed ID: 12952753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of phenytoin therapy on the skin and skin disease.
    Scheinfeld N
    Expert Opin Drug Saf; 2004 Nov; 3(6):655-65. PubMed ID: 15500423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3 cases of malignant lymphoma or pseudolymphoma in epileptics treated with diphenylhydantoin].
    Alberto P; Cougn R; Maurice P; Weber J
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1773-4. PubMed ID: 5140914
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lymphadenopathy in phenytoin treatment].
    Marg E; Köpke E; Schillat I
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jul; 30(7):430-6. PubMed ID: 100800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of "exanthematous pseudolymphoma" due to diphenylhydantoin hypersensitivity with a transitory immunologic deficit].
    Vellucci A; Galanti G; Pezzella B; De Longis P; Colacecchi C
    Clin Ter; 1980 Jul; 94(2):229-37. PubMed ID: 7449346
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced liver injury. In vitro demonstration of hypersensitivity to both phenytoin and phenobarbital.
    Kahn HD; Faguet GB; Agee JF; Middleton HM
    Arch Intern Med; 1984 Aug; 144(8):1677-9. PubMed ID: 6466024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin hypersensitivity syndrome masquerading as fever and systemic illness of unknown origin in an HIV-infected patient.
    Bedimo RJ; Geisler WM
    Int J STD AIDS; 2005 Feb; 16(2):178-9. PubMed ID: 15807950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins.
    Lopez S; Torres MJ; Rodríguez-Pena R; Blanca-Lopez N; Fernandez TD; Antunez C; Canto G; de Luque V; Mayorga C
    Br J Dermatol; 2009 Feb; 160(2):259-65. PubMed ID: 18945304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psuedolymphoma syndrome.
    Halevy S; Feuerman EJ
    Dermatologica; 1977; 155(6):321-7. PubMed ID: 144619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced pseudolymphoma with predominantly cutaneous manifestation].
    Sigal M; Pulik M
    Ann Dermatol Venereol; 1993; 120(2):175-80. PubMed ID: 8363313
    [No Abstract]   [Full Text] [Related]  

  • 20. Generalized nodular cutaneous pseudolymphoma associated with phenytoin therapy. Use of T-cell receptor gene rearrangement in diagnosis and clinical review of cutaneous reactions to phenytoin.
    Braddock SW; Harrington D; Vose J
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 2):337-40. PubMed ID: 1517500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.